Obiezu Christina V, Diamandis Eleftherios P
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont., Canada M5G 1X5.
Cancer Lett. 2005 Jun 16;224(1):1-22. doi: 10.1016/j.canlet.2004.09.024.
Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes. Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes. These genes, and their protein products, share a high degree of homology and are expressed in a wide array of tissues, mainly those that are under steroid hormone control. PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker. In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been associated with several types of cancer. For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer. New evidence raises the possibility that some kallikreins are directly involved with cancer progression. We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.
人组织激肽释放酶基因位于19号染色体长臂,是蛋白水解酶丝氨酸蛋白酶家族的一个亚群。最初认为人激肽释放酶基因座由三个成员组成,现在其范围已扩展,包括15个串联排列的基因。这些基因及其蛋白质产物具有高度同源性,在多种组织中表达,主要是那些受类固醇激素控制的组织。前列腺特异性抗原(hK3)是人激肽释放酶之一,是前列腺癌筛查、诊断、预后和监测中最有用的肿瘤标志物。hK2是另一种前列腺特异性激肽释放酶,也被提议作为前列腺癌的补充生物标志物。在过去5年中,新发现的激肽释放酶(KLK4 - KLK15)已与多种类型的癌症相关。例如,hK4、hK5、hK6、hK7、hK8、hK10、hK11、hK13和hK14正成为卵巢癌、乳腺癌、前列腺癌和睾丸癌的生物标志物。新证据表明一些激肽释放酶可能直接参与癌症进展。我们在此综述激肽释放酶与癌症相关的证据及其作为癌症诊断和管理新生物标志物的适用性。